stella
beta
Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer — Stella
Home
/
HER2-positive Metastatic Breast Cancer
/
Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer
View on ClinicalTrials.gov
Recruiting
Back to HER2-positive Metastatic Breast Cancer trials
Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
United States
University of Miami, Miami, Florida